To determine the effect of TAPBPL on experimental arthritis, DBA/1 mice on day 0 were injected with CII emulated in complete Freund adjuvant (CFA) and on day 21 were given a booster of CII in incomplete Freund adjuvant (IFA). Here, TAPBPL is linked to arthritic joint disease.